Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Study of Platelet Derived Growth Factor Receptor (PDGFR) in Recurrent Malignant Gliomas

This study is currently recruiting participants. (see Contacts and Locations)
Verified May 2014 by University of California, San Diego
Sponsor:
Collaborator:
Novartis
Information provided by (Responsible Party):
Santosh Kesari, M.D., Ph.D., University of California, San Diego
ClinicalTrials.gov Identifier:
NCT01140568
First received: June 8, 2010
Last updated: May 21, 2014
Last verified: May 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: August 2015
  Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)